In the largest comparison of angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors to date, a study of nearly 2.3 million patients starting the drugs as monotherapy ...

Credit: Getty Images. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines. Angiotensin receptor ...

Angiotensin II receptor blockers (ARBs) are drugs that treat certain conditions affecting the heart and blood vessels as well as a kidney condition resulting from diabetes. People generally tolerate ...

High blood pressure and cardiovascular and renal diseases are often treated with a combination of renin-angiotensin-aldosterone system inhibitors. However, as these agents have the potential to cause ...

(UPDATED) Another observational study, in the form of a large analysis of US patients with hypertension, indicates that ACE inhibitors and ARBs are not associated with an increased risk of COVID-19 ...

Angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) are recommended widely as first-line treatments for hypertension in patients with diabetic or nondiabetic ...